These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 34186172)

  • 1. Environmental exposure unit simulates natural seasonal birch pollen exposures while maximizing change in allergic symptoms.
    Ellis AK; DeVeaux M; Steacy L; Ramesh D; Suprun M; Langdon S; Wang CQ; Adams D; Thiele J; Walker T; Perlee LT; O'Brien MP
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):488-495.e5. PubMed ID: 34186172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
    Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H
    Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH; Briscoe M; Widlitz MD
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of controlled exposure to birch pollen in the Environmental Exposure Unit (EEU).
    Ellis AK; Soliman M; Steacy LM; Adams DE; Hobsbawn B; Walker TJ
    Allergy Asthma Clin Immunol; 2016; 12():53. PubMed ID: 27777594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of airborne birch pollen levels on clinical symptoms of seasonal allergic rhinoconjunctivitis.
    Caillaud D; Martin S; Segala C; Besancenot JP; Clot B; Thibaudon M;
    Int Arch Allergy Immunol; 2014; 163(1):43-50. PubMed ID: 24247974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma.
    Pfaar O; Bachert C; Kuna P; Panzner P; Džupinová M; Klimek L; van Nimwegen MJ; Boot JD; Yu D; Opstelten DJE; de Kam PJ
    J Allergy Clin Immunol; 2019 Mar; 143(3):970-977. PubMed ID: 30508538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis.
    Kuehr J; Brauburger J; Zielen S; Schauer U; Kamin W; Von Berg A; Leupold W; Bergmann KC; Rolinck-Werninghaus C; Gräve M; Hultsch T; Wahn U
    J Allergy Clin Immunol; 2002 Feb; 109(2):274-80. PubMed ID: 11842297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cockroach sensitization mitigates allergic rhinoconjunctivitis symptom severity in patients allergic to house dust mites and pollen.
    He W; Jimenez F; Martinez H; Harper NL; Manoharan MS; Carrillo A; Ingale P; Liu YG; Ahuja SS; Clark RA; Rather CG; Ramirez DA; Andrews CP; Jacobs RL; Ahuja SK
    J Allergy Clin Immunol; 2015 Sep; 136(3):658-66. PubMed ID: 26026342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system.
    Day JH; Briscoe M; Rafeiro E; Chapman D; Kramer B
    Ann Allergy Asthma Immunol; 2001 Dec; 87(6):474-81. PubMed ID: 11770694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit.
    Day JH; Briscoe MP; Ratz JD; Ellis AK; Yao R; Danzig M
    Allergy Asthma Proc; 2009; 30(3):270-6. PubMed ID: 19549428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.
    Hampel FC; Pedinoff AJ; Jacobs RL; Caracta CF; Tantry SK
    Allergy Asthma Proc; 2019 Jul; 40(4):261-272. PubMed ID: 31053180
    [No Abstract]   [Full Text] [Related]  

  • 13. Conjunctival provocation tests: a predictive factor for patients' seasonal allergic rhinoconjunctivitis symptoms.
    Kruse K; Gerwin E; Eichel A; Shah-Hosseini K; Mösges R
    J Allergy Clin Immunol Pract; 2015; 3(3):381-6. PubMed ID: 25609338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study.
    Bødtger U; Poulsen LK; Jacobi HH; Malling HJ
    Allergy; 2002 Apr; 57(4):297-305. PubMed ID: 11906359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study.
    Cirla AM; Cirla PE; Parmiani S; Pecora S
    Allergol Immunopathol (Madr); 2003; 31(1):31-43. PubMed ID: 12573207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
    Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
    Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic and acute treatment with the homeopathic medicine, Betula 30c for birch pollen allergy: a double-blind, randomized, placebo-controlled study of consistency of VAS responses.
    Aabel S
    Br Homeopath J; 2001 Apr; 90(2):73-8. PubMed ID: 11341460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes.
    Jacobs RL; Harper N; He W; Andrews CP; Rather CG; Ramirez DA; Ahuja SK
    J Allergy Clin Immunol; 2012 Jul; 130(1):122-7.e8. PubMed ID: 22554707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validation of controlled grass pollen challenge in the Environmental Exposure Unit (EEU).
    Ellis AK; Steacy LM; Hobsbawn B; Conway CE; Walker TJ
    Allergy Asthma Clin Immunol; 2015; 11(1):5. PubMed ID: 25653682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.